Velocity-Loss Training and Parkinson's Disease
Comparison of Neuromuscular and Functional Adaptations to 10% and 30% Velocity-Loss Threshold Resistance Training in Persons With Parkinson's Disease
This study will compare the effects of velocity-loss resistance training at 10% and 30% velocity loss thresholds on measures of muscle strength and power and tests of daily performance in older adults with Parkinson's disease.
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Joseph F. Signorile, PhD
- Phone Number: 3052843105
- Email: jsignorile@miami.edu
Study Contact Backup
- Name: Ethan A Elkins, MS
- Phone Number: 3052844173
- Email: exe453@miami.edu
Study Locations
-
-
Florida
-
Coral Gables, Florida, United States, 33147
- Recruiting
- Laboratory of Neruomuscular Research and Active Aging
-
Contact:
- Joseph F Signorile, PhD
- Phone Number: 305-284-3105
- Email: jsignorile@miami.edu
-
Principal Investigator:
- Joseph Signorile, PhD
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Parkinson's Disease Hoehn & Yahr Stages 1-3
- Able to walk 50 meters unassisted
- Able to understand and communicate in English
Exclusion Criteria:
- Uncontrolled cardiovascular or other neuromuscular disease that prevent participation in a training program
- Any systemic inflammatory or autoimmune conditions such as rheumatoid arthritis, or other serious concomitant medical illness
- Unresolved injury or surgery to the upper or lower limbs that prevents weight training.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: 10% Velocity-Loss Threshold Resistance Training
Participants will receive velocity-based resistance training at 10% velocity-loss threshold, twice per week for at least 24 sessions for up to 12 weeks. |
Participants will receive a total of twenty-four 45-minutes in-person training sessions at 10% velocity-loss threshold, twice per week using three sets of eight repetitions per set. During training participants will be allowed 1-minute rests between sets. Exercises will include four upper-body exercises and 2 lower-body exercises. |
|
Experimental: 30% Velocity-Loss Threshold Resistance Training
Participants will receive velocity-based resistance training at 30% velocity-loss threshold, twice per week for at least 24 sessions for up to 12 weeks. |
Participants will receive a total of twenty-four 45-minutes in-person training sessions at 30% velocity-loss threshold, twice per week using three sets of eight repetitions per set. During training participants will be allowed 1-minute rests between sets. Exercises will include four upper-body exercises and 2 lower-body exercises. |
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in neuromuscular performance as measured by 1-repetition maximum (1RM)
Time Frame: Baseline, 12 weeks
|
Maximal load that can be lifted in one repetition (1RM) will be assessed in both leg press and chest press exercises. The loads on the testing equipment will be increased across 5 to 7 testing repetitions. The persons 1RM will be the highest load the person can move through the range of motion of the exercise. There are no minimum or maximum scores for this test. The higher the 1RM the stronger the person is. The unit of measurement is kilograms. |
Baseline, 12 weeks
|
|
Change in neuromuscular performance as measured by Watts
Time Frame: Baseline, 12 weeks
|
This test measures the power a person can produce at maximal speed using loads of 20%, 40%, 60%, 80%, and 90% of 1RM for the chest press and leg press. Power shows how fast a person can do work. There are no minimum or maximum possible values. Higher values indicate better neuromuscular performance. Unit of measure is Watts. |
Baseline, 12 weeks
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in the Speed of the Ten-Meter Walk Test.
Time Frame: Baseline, 12 weeks
|
The ten-meter walk test will be used to assess gait velocity. The participants will be asked to walk at usual walking speed and as quickly as possible in a straight line on a 10-meter (m) course marked at 0, 2, 8 and 10 m. On verbal command, participants will start on the 0-m mark and stop when the 10-m mark is crossed. The total time to ambulate from the 2-m mark to the 8-m mark (6 m total) will be timed to the hundredth of a second. Two trials will be performed at each speed, and the average will be documented in meters per second. One-minute recoveries will be provided between trials. |
Baseline, 12 weeks
|
|
Change in Time for the Five Times Sit-to-Stand Test.
Time Frame: Baseline, 12 weeks
|
The five-time sit-to-stand test will be used to assess functional lower body strength. The participant will sit with arms folded across the chest and the back against the chair. On a verbal command, the participant will stand up and sit down five times as quickly as possible. Timing begins at the word go and ends when the buttocks touch the chair after the fifth repetition. One practice and two testing trials will be performed. Time will be measured in seconds. |
Baseline, 12 weeks
|
|
Change in the time required to complete the timed Up-and-Go Test.
Time Frame: Baseline, 12 weeks
|
Upon verbal cue, participants will stand up, walk around a cone placed three meters from the front edge of the chair and then returns to a seated position as quickly as possible. Time is measured in seconds. |
Baseline, 12 weeks
|
|
Change in Distance of the Seated Medicine Ball Throw.
Time Frame: Baseline, 12 weeks
|
Upper body power will be assessed using the Seated Medicine Ball Throw test. Participants will sit in an armless chair with their back against the chair back and throw a 6-pound medicine ball from the chest as far as possible at an approximate 45-degree angle. Participants will complete three recorded test attempts. The distance thrown in meters will be measured. There are no minimum or maximum possible values. Greater throwing distances indicate better upper body power. |
Baseline, 12 weeks
|
|
Change in Muscle Thickness using Ultrasound.
Time Frame: Baseline, 12 weeks
|
Muscle thickness will be assessed using B-mode ultrasonography. Three longitudinal-view images will be obtained for each muscle assessed. Muscle thickness will be measured by drawing a perpendicular line from the superficial aponeurosis to the deep aponeurosis at the thickest region of the muscle. Assessments will be performed on selected thigh and upper arm muscles. Muscle thickness is measured in centimeters (cm). Higher values indicate greater muscle thickness. |
Baseline, 12 weeks
|
|
Change in Muscle Quality using Ultrasound.
Time Frame: Baseline, 12 weeks
|
Muscle quality will be measured using a gray scale. Grayscale values range from 0 to 255 units, where lower values (darker pixels) indicate greater muscle tissue content and higher values (lighter pixels) indicate greater intramuscular fat. The muscle to be tested will be the thigh muscles and the back of your arm. Lower grayscale values indicate better muscle quality. |
Baseline, 12 weeks
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Joseph F. Signorile, PhD, University of Miami - Coral Gables Campus
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 20260975
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.